chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Started vomiting evening of 8/14-had episode of posturing with head turned to light eyes of evened  right and twitching, some tongue twitching and rigidity right side.  Not responsive to parent's touch or stimulation brought to emergency department per paramedics. Let the above episodes witnessed in emergency department. D/C summary included eyes rolling up & dehydration.
Patient received her second COVID-19 vaccine on 12/08/2021 shortly after 4 PM. Mother reports that about one hour later, she experienced a sudden bout of diarrhea at home. She experienced another about of diarrhea around 8:30 PM (it woke her up from sleep), and then she had generalized itchiness without hives. This morning, she is doing much better and still has scattered areas of itchiness. Advised mother to give oral Benadryl (which she did not do the night prior).  She was otherwise well without sign of illness prior to the vaccine yesterday.
This spontaneous case reported by a consumer, describes the occurrence of vaccination site rash (red rash in the injection site that spread all over her upper arm), vaccination site pruritus (arm is very itchy) and vaccination site discharge (arm looks splashy) in a 45-year-old female patient who received mRNA-1273 (Moderna COVID-19 vaccine, batch# 011J20A) for COVID-19 immunization. No medical history provided. On Jan 15, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; 1 dosage form. On Jan 11, 2021, patient experienced vaccination site rash (red rash in the injection site that spread all over her upper arm), vaccination site pruritus (arm is very itchy) and vaccination site discharge (arm looks splashy). At the time of the report, vaccination site rash (red rash in the injection site that spread all over her upper arm), vaccination site pruritus (arm is very itchy) and vaccination site discharge (arm looks splashy) outcome: unknown. The action taken with mRNA-1273 (Moderna COVID-19  vaccine), intramuscular: unknown.
Patient  husband came with wife for 4th dose for Moderna booster 01/19/2022. Pharmacy shared information that patient has to wait 5 month after 3rd dose. However Pharmacist discovered at that time patient is immunocompromised and she should have get 3rd dose 0.5ml. Patient was not aware of third dose at time 10/22/2021. Patient came for booster after 6 month of second dose and pharmacy administer as booster 0.25ml.Pharamcy administer dose as patient requested dose at time on 10/22/21.Pharmacy tried find out from  patient  husband why they did not receive 3rd dose and husband mention they never heard of 3rd dose and as soon as they heard for booster they came for booster dose
After receiving her 2 month old vaccinations, my child developed a red, scaly, itchy rash on her face and body. Her doctor has prescribed the rash as eczema.
Upon receipt of vaccine Pt. reported immediate burning (more than normal). During evening hours arm soreness became worse. Pt. had difficult time lifting arm over head which continues to date. No treatment sought.
Cold sore, mouth sores, itchy burning eyes, abdominal rash, itchy skin head to toe, vertigo, dry cough, shortness of breath, traveling leg pain, development of ear infection, dizziness
a patient who missed the second vaccination how does she proceed it's approximately two weeks late now; This spontaneous case was reported by a physician (subsequently medically confirmed) and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (a patient who missed the second vaccination how does she proceed it's approximately two weeks late now) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (a patient who missed the second vaccination how does she proceed it's approximately two weeks late now). At the time of the report, PRODUCT DOSE OMISSION ISSUE (a patient who missed the second vaccination how does she proceed it's approximately two weeks late now) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   This report refers to a case of Product dose omission issue for mRNA-1273 (lot number unknown) with no associated  reported.; Sender's Comments: This report refers to a case of Product dose omission issue for mRNA-1273 (lot number unknown) with no associated reported.
SUSPECTED COVID-19 INFECTION; This spontaneous report received from a health care professional (Nurse) concerned a 63 year old female of an unspecified ethnicity. The patient's weight, height, and medical history were not reported. The patient had previously received covid-19 vaccine ad26.cov2.s (Dose number in series 1) (suspension for injection, route of admin and batch number were not reported, and expiry: Unknown) dose was not reported, 1 total, dose 1 was administered on an unspecified date in MAR-2021 for covid-19 prophylaxis. It was unknown whether patient had any adverse events following vaccination with covid-19 vaccine ad26.cov2.s (Dose number in series 1). The patient received covid-19 vaccine ad26.cov2.s (Dose number in series 2) (suspension for injection, route of admin and batch number were not reported, and expiry: Unknown) dose was not reported, 1 total, dose 2 was administered on an unspecified date in NOV-2021 for covid-19 prophylaxis. The batch number was not reported and has been requested. Age at time of vaccination 62 years old. No concomitant medications were reported. On 16-SEP-2022, the patient experienced symptoms of covid included regular cold, blowing nose, worst sore throat which felt like swallowing razor blades, nasal congestion and fever which was suspected covid-19 infection (Dose number in series 2). The patient kept checking oxygen and blood pressure results were not reported. The patient was started on antivirals (unspecified) given by doctor, and then the patient tested negative on an unspecified date. After testing negative the patient experienced feeling in her chest for about 3 months that went away, heart rate increased, nose kept draining and draining while wearing a mask, and had short of breath (Dose number in series 2). These were side effects after testing negative or long covid. Laboratory data (dates unspecified) included: Blood pressure not reported, COVID-19 virus test Negative, Heart rate increased, and Oxygen saturation not reported. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of suspected covid-19 infection was not reported. This report was non-serious.
I went to stay with my son after the vaccine and I couldn't wake up for 1-2 days. I was very very tired.
similar large local urticarial reaction at the injection site only; This is a spontaneous report received from a contactable reporter(s) (Physician).  A 5 year-old male patient received bnt162b2 (BNT162B2), intramuscular, administered in arm left, administration date 03Dec2021 (Batch/Lot number: unknown) at the age of 5 years as dose 2 (tris), single for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. Vaccination history included: Bnt162b2 (1st Dose, Prev dose product: COVID 19, Prev dose Brand: Pfizer COVID-19, Prev dose Brand unknown: False, Prev dose Lot unknown: True, Prev dose Lot unknown reason: Not available/provided to reporter at the time of report completion, Prev dose administration date: 06Nov2021, Prev dose Dose number: 1), administration date: 06Nov2021, when the patient was 5 years old, for COVID-19 immunization, reaction(s): "had a local urticarial reaction that self resolved each time, occurred after a warm shower". The following information was reported: VACCINATION SITE URTICARIA (non-serious) with onset 09Dec2021 16:30, outcome "recovered", described as "similar large local urticarial reaction at the injection site only". Therapeutic measures were not taken as a result of vaccination site urticaria.  Additional information: The reporter type was Healthcare Professional reporting for a patient. The age group of the patient was "child (2-11 years)". 1st injection was 06Nov2021. On 08Nov2021 and then again on 09Nov2021, had a local urticarial reaction that self resolved each time, occurred after a warm shower. No other symptoms at all, either at the time of the injection nor at each episode of local urticaria. The 2nd injection was on 03Dec2021. No issues at all once again at the time of the injection. No issues at all until 09Dec2021 after a warm shower, similar large local urticarial reaction at the injection site only. Again, self resolved. No any other vaccine in four weeks. The Covid was not tested post vaccination. There was no known allergies and none other medical history. Other medications in two weeks was none  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
burning nerve endings; terrible aches and pains; Tiredness; Headache; Chills; had nauseousness; joint pain; she says she went to the urgent care place yesterday she was so sick; Fever; This is a spontaneous case received from a contactable consumer (patient). An 84-year-old female patient received first dose of bnt162b2 (BNT162B2, PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, Batch/Lot number was not reported) via an unspecified route of administration in arm right on an unknown date as DOSE 1, SINGLE (age at vaccination 84-year-old) for COVID-19 immunisation. The patient medical history included arthritis. Concomitant medication was reported as none. The patient did not take any other vaccinations. On an unknown date, the patient experienced terrible aches and pains, tiredness, headache, chills, joint pain, nausea and reported that she had been so sick. On 12Mar2021, the patient experienced fever. The patient underwent lab test and procedures which included body temperature: 101 Fahrenheit on 12Mar2021. Adverse events resulted in emergency room visit. Therapeutic measures were taken as a result of the events which included treatment with Tylenol. The outcome of the event (burning nerve endings) was not recovered and the outcome for other events was unknown.  No follow-up attempts are possible. Information on Batch number, Lot number cannot be obtained.
I have developed a constant low hum in my left ear, as if some machine is operating in my house, or always on the other side of the wall of whatever room I'm in.
After receiving my 2nd shot of the fizer vaccine I started to notice occasional ringing in my ears. It comes and goes.When I had a clogged nose for about 2-3 weeks they were ringing everyday. I had experienced ringing before but only once in  a blue moon like once every couple of months.  For the last 3 weeks it's been daily off and on. But I did have a clogged nose and running nose that I thogh might be some kind of allergy. The clogged nose problem has gone away after 3 weeks but I'm stuill experiencing the ringing in my ears. I thought It might be some kind of complication from sinuses since my nose was clogged and I was experiencing sinus pressure while my nose was clogged. Now all symptoms have gone away except for the ear ringing.
Pt. was given an expired Kinrix vaccine EXP 03/03/2023, child was doing fine. Mother was notified of incident and follow up appointment given.
I received my Pfister covid shot on 11/3/2021 in the Left arm. Two days later I woke up with a rash all over my body from head to toe big red welts that itch and are splotchy. I've took Benadryl, Claritin. Nothing isn't helping and I just feel as if my rash is getting worse.
Information has been received from a 25 year old female patient, with diabetes and a negative titer for rubella, who was vaccinated with a dose of MMR II. Post vaccination the patient's titer remained negative. The vaccine was repeated 2 more times at varying intervals after the birth if her three children. The patient's last titer was 5 years ago, in approximately 1997, and remained negative. Unspecified medical attention was sought. Additional information has been requested. The patient also reported a similar experience with MMR.
Patient received flu shot on Saturday 9/29/2018, on Monday or Tuesday of the following week she developed flu like symptoms and sore throat. The following Friday she developed a severe migraine headache. She has continued nausea, lightheadedness, and car sickness.
Local reaction to DTaP #4 given in right arm on 06/04/02 approx. 8 x 4cm redness, warmth. Follow-up 06/08/02.
rash around the injection site; was flushed; face and ears were warm to touch; face and ears were bright red; This spontaneous case was reported by a consumer and describes the occurrence of FLUSHING (was flushed), HOT FLUSH (face and ears were warm to touch), ERYTHEMA (face and ears were bright red) and VACCINATION SITE RASH (rash around the injection site) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Hypertension, Hypothyroidism, Pollen allergy and Grass allergy.    On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Mar-2021, the patient experienced FLUSHING (was flushed), HOT FLUSH (face and ears were warm to touch) and ERYTHEMA (face and ears were bright red). On 09-Mar-2021, the patient experienced VACCINATION SITE RASH (rash around the injection site). On 02-Mar-2021, FLUSHING (was flushed) had resolved. At the time of the report, HOT FLUSH (face and ears were warm to touch), ERYTHEMA (face and ears were bright red) and VACCINATION SITE RASH (rash around the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications includes medication for hypertension and hypothyroidism. Treatment with Benadryl  was provided for rash.   This case was linked to MOD-2021-110249 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 05-May-2021: Event outcome provided.
Severe vertigo for two days.  Called therapist and was repositioned and I did a series of  exercises for balance for 5 months with no or  little improvement, which is unusual. Have to use cane for walking   Recent bout of vertigo that will not go away.  Am taking prednizone tablets for a week for more help. This is very dibilitating for me.  My son wants me to take Ivermechin for some help.
I developed a very bad headache that got worse and worse through the day. Early that night, around 8:30pm, I decided to go to bed to try and sleep off the headache. 2 hours later I woke up after having very intense distorted dreams and began throwing up, had diarrhea, and shaking very bad. I felt flushed and very hot but did not have a fever. This went on for a couple hours.
This spontaneous report as received from a physician refers to a 19 year old female patient. In Jun-1997 and AUG-2012 the patient was vaccinated with VARIVAX (Merck). On 06-DEC-2014 a panel of IgG titers drawn showed varicella virus test negative. No treatment was given. The outcome was reported as not recovered. See MARRS# 1501USA007199 for event involving MMR. This is one of 2 reports received from the same source. Additional information has been requested.
This spontaneous report as received from a licensed practical nurse on behalf of a doctor of osteopathy refers to several patients of unknown age and gender. The patients were vaccinated with PNEUMOVAX 23 on unknown dates. No other co-suspects were reported. No concomitant medications were reported. The patients experienced localized reactions (swelling, pain and erythema more than typical) with the PNEUMOVAX 23. Physician stated they had had several of these reactions as well. Treatment information was not reported. At the time of reporting, the patient's outcome was unknown. Relatedness was not provided. This is one of 2 reports from the same source. Additional information has been requested.
cold; heaviness; pain on the arm of injection (L arm) that spread to the back; pain on the arm of injection (L arm) that spread to the back; chills; fever 101F; headache; body ache; vomiting; joint pain/knee pain; This spontaneous case was reported by a consumer and describes the occurrence of NASOPHARYNGITIS (cold), LIMB DISCOMFORT (heaviness), BACK PAIN (pain on the arm of injection (L arm) that spread to the back), PAIN IN EXTREMITY (pain on the arm of injection (L arm) that spread to the back) and CHILLS (chills) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 on 04-Dec-2020. Concomitant products included AMLODIPINE, VITAMIN B12 [VITAMIN B12 NOS], MULTIVITAMIN [VITAMINS NOS], FISH OIL (OMEGA 3 [FISH OIL]) and VITAMIN C [ASCORBIC ACID] for an unknown indication.    On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Mar-2021, the patient experienced NASOPHARYNGITIS (cold), LIMB DISCOMFORT (heaviness), BACK PAIN (pain on the arm of injection (L arm) that spread to the back), PAIN IN EXTREMITY (pain on the arm of injection (L arm) that spread to the back), CHILLS (chills), PYREXIA (fever 101F), HEADACHE (headache), MYALGIA (body ache), VOMITING (vomiting) and ARTHRALGIA (joint pain/knee pain). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at a dose of UNK, qid. At the time of the report, NASOPHARYNGITIS (cold), LIMB DISCOMFORT (heaviness), BACK PAIN (pain on the arm of injection (L arm) that spread to the back), PAIN IN EXTREMITY (pain on the arm of injection (L arm) that spread to the back), CHILLS (chills), PYREXIA (fever 101F), HEADACHE (headache), MYALGIA (body ache), VOMITING (vomiting) and ARTHRALGIA (joint pain/knee pain) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 04-Dec-2020, COVID-19: positive (Positive) COVID-19 with mild symptoms.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Patient had pO2 97 mmHg. Patient reported that she has had all the side effects that are listed on the Fact Sheet she was given except for the ones of severe allergic reaction.
Uterine cramping, intense vaginal bleeding similar to a menstrual period. Soaking pads every 2 hours for first 2 days, then moderate bleeding for the next 3 days. Completely unexpected, not listed on the vaccine data sheet as a possible side effect. It was not my normal time for menstruation.
No other AE/PQC reported.; an expired dose of PNEUMOVAX23 PFS was inadvertently administered to a patient.; This spontaneous report has been received from a pharmacist referring to a patient of unknown age and gender. Information about medical history, concurrent conditions, concomitant therapies and drug allergies was not provided.      On 19-JUL-2021, the patient was inadvertently vaccinated with an expired dose of pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) pre-filled syringe (PFS) (lot #: R033343, expiration date: 03-AUG-2020; route and dose details were not provided) for prophylaxis (expired product administered). The product never had a temperature excursion. No other adverse event (AE)/ product quality compliant (PQC) reported. combinationproductreport: Yes; brandname: PNEUMOVAX23 SYRINGE (DEVICE); commondevicename: Pneumococcal Vaccine, Polyvalent (23-valent); productcode: FMF; devicetype: SYRINGE, PISTON (FMF); manufacturername: Merck Sharp & Dohme Corp.; devicelotnumber: R033343; expirationdate: 03-AUG-2020; deviceage and unit: 0 ; malfunction: Unknown; deviceusage: Initial; reasonfornoneval: 81 Other; labeledsingleusedevice: No; mdcpreportability: No; mdcpreprationale: Case information does not meet criteria for reportability
Three weeks after receiving vaccine, developed a maculopapular rash on body, front and back. When seen at clinic 10/16/02, a few were vesicular and rash was spreading to face, arms and legs. Very itchy. Treatment recommended was palliative-Benadryl, avoid scratching, luke warm bath, and exclude from school for 5 days.
12/15/00 Phone call from mother stating that she took pt to ER with 100.5 temp. and baseball size knot on right thigh state, given antibiotic for infection form ER MD. 13:00 lesion measured 8cm x 13cm, red, hot to touch , cellulitis, mother will see MD today to seek intervention.
very swollen upper arm, bright red & very hard; nodule a little larger than pea-size;
Member reports that after receiving his 4th Anthrax vaccination, he developed bilateral knee joint pain and left elbow joint pain.  This lasted for approximately one month.  He sought medical attention and was started on Naprosyn 500mg two times a day for  7 days.  His symptoms improved.
Patient came to clinic for visit 1.5 wks after immunizations for a generalized rash.  Primarily papular, starting on face and spreading caudally.  The papules become pustules and rupture, or heal with an intermediate period as urticarial rash.  Some excoriations.
Rash and itching left rib cage and left inner thigh.  Benadryl OTC taken that night and the next morning with relief of symptoms.  Also had 102F temp and muscle aches.  Took OTC Ibuprofen.
Redness & swelling at site seen 3/27/12 numbness, tingling of hand, thumb, 1st 2 digits on 4/2/12 4/5 worsening of numbness.
Quarter-sized red, raised area around injection site. Fussiness. Treated with 1.25ml dose of infants' concentrated ibuprofen.
Rash developed after flu vaccine (3 days) in centrifugal distribution macular, non itching suggestive of possible flu vaccine reaction, unlikely to be due to amoxil, reviewed PI no mention of rash with flu vaccine though.
Painful and  swollen Rash  on her left arms. Pt had to go to ER and was prescribed steroid for 1 week.
PT stated she felt funny. Began assessment. PT lost pulse, began CPR. PT regained pulse, was transferred via EMS to hospital
This spontaneous report as received from a registered nurse refers to a 16 year old patient of unknown gender. The patient's relevant medical history, concurrent conditions, concomitant medications, drug reactions or allergies were not reported. On 15-SEP-2017, the patient was vaccinated with improperly stored GARDASIL 9 (dosing details were not reported) (lot # N019923, expiry date: 28-APR-2019) for prophylaxis. No adverse effects were reported. Temperature excursion was from 0 degree Celsius (C) to 1 degree C (0.8 degree C) for 52 minutes. The previous temperature excursion was reported as from 9 degree C to 25 degree C (10.9 degree C) for 3 hours 17 minutes. The call was because of a data logger. No product quality complaint involved. This is one of several reports received from the same reporter. Sender's Comments: US-009507513-1709USA000054: US-009507513-1709USA007012: US-009507513-1709USA007011: US-009507513-1709USA007014.